关于：使用抗毒蕈碱药物治疗膀胱过度活动症患者；心率相关考量。 - Suppr

Suppr

超能文献

Re: Treating patients with overactive bladder symptoms with antimuscarinics; heart rate considerations.

作者信息

Wyllie Michael G

出版信息

BJU Int. 2008 Jan;101(1):129. doi: 10.1111/j.1464-410X.2007.07380_3.x.

DOI:10.1111/j.1464-410X.2007.07380_3.x

PMID:18086105

Abstract

摘要

相似文献

Re: Treating patients with overactive bladder symptoms with antimuscarinics; heart rate considerations.

BJU Int. 2008 Jan;101(1):129. doi: 10.1111/j.1464-410X.2007.07380_3.x.

Treating patients with overactive bladder syndrome with antimuscarinics: heart rate considerations.

BJU Int. 2007 Nov;100(5):1007-14. doi: 10.1111/j.1464-410X.2007.07100.x.

Better management of patients with overactive bladder with antimuscarinics?

Int J Clin Pract. 2008 Jan;62(1):3-4. doi: 10.1111/j.1742-1241.2007.01627.x.

What happened when I took OAB drugs?

Neurourol Urodyn. 2007;26(7):1057. doi: 10.1002/nau.20454.

Antimuscarinics and cognitive function.

Eur Urol. 2006 Aug;50(2):211-2. doi: 10.1016/j.eururo.2006.03.060. Epub 2006 Apr 19.

Preclinical compounds for the treatment of overactive bladder.

Expert Opin Ther Pat. 2009 Feb;19(2):107-17. doi: 10.1517/13543770802672606.

Open to debate. The Motion: antimuscarinics are the mainstay of therapy for overactive bladder.

Eur Urol. 2008 Jul;54(1):226-30. doi: 10.1016/j.eururo.2008.04.020. Epub 2008 Apr 16.

Sensory effects of antimuscarinics: still a matter of debate.

Eur Urol. 2010 Jul;58(1):29-30. doi: 10.1016/j.eururo.2010.01.010. Epub 2010 Jan 18.

Changing treatments for overactive bladder.

Nurs Times. 2008;104(41):45-8.

Overactive bladder medicines and cognitive testing.

Int J Clin Pract. 2008 Nov;62(11):1641-2. doi: 10.1111/j.1742-1241.2008.01915.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Re: Treating patients with overactive bladder symptoms with antimuscarinics; heart rate considerations.

BJU Int. 2008 Jan;101(1):129. doi: 10.1111/j.1464-410X.2007.07380_3.x.

Treating patients with overactive bladder syndrome with antimuscarinics: heart rate considerations.

BJU Int. 2007 Nov;100(5):1007-14. doi: 10.1111/j.1464-410X.2007.07100.x.

Better management of patients with overactive bladder with antimuscarinics?

Int J Clin Pract. 2008 Jan;62(1):3-4. doi: 10.1111/j.1742-1241.2007.01627.x.

What happened when I took OAB drugs?

Neurourol Urodyn. 2007;26(7):1057. doi: 10.1002/nau.20454.

Antimuscarinics and cognitive function.

Eur Urol. 2006 Aug;50(2):211-2. doi: 10.1016/j.eururo.2006.03.060. Epub 2006 Apr 19.

Preclinical compounds for the treatment of overactive bladder.

Expert Opin Ther Pat. 2009 Feb;19(2):107-17. doi: 10.1517/13543770802672606.

Open to debate. The Motion: antimuscarinics are the mainstay of therapy for overactive bladder.

Eur Urol. 2008 Jul;54(1):226-30. doi: 10.1016/j.eururo.2008.04.020. Epub 2008 Apr 16.

Sensory effects of antimuscarinics: still a matter of debate.

Eur Urol. 2010 Jul;58(1):29-30. doi: 10.1016/j.eururo.2010.01.010. Epub 2010 Jan 18.

Changing treatments for overactive bladder.

Nurs Times. 2008;104(41):45-8.

Overactive bladder medicines and cognitive testing.

Int J Clin Pract. 2008 Nov;62(11):1641-2. doi: 10.1111/j.1742-1241.2008.01915.x.